Stephan Weidinger

GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets

Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE

Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions

The role of OX40 ligand/OX40 axis signalling in atopic dermatitis

Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective

Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials

Kenntnisse und tatsächliche Umsetzung der Empfehlungen zur Prävention des plötzlichen Säuglingstods innerhalb des ersten Lebensjahres – eine Analyse longitudinaler Daten der KUNO Kids Gesundheitsstudie

Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study

Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate‐to‐severe atopic dermatitis

Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany

Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial

Implementation of safe infant sleep recommendations during night-time sleep in the first year of life in a German birth cohort

Host genetic factors related to innate immunity, environmental sensing and cellular functions are associated with human skin microbiota

Biomarkers of disease progression in people with psoriasis: a scoping review

Skin care interventions in infants for preventing eczema and food allergy

Blood transcriptome profiling identifies 2 candidate endotypes of atopic dermatitis

Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Biomarkers of systemic treatment response in people with psoriasis: a scoping review

Direct cellular reprogramming enables development of viral T antigen–driven Merkel cell carcinoma in mice

Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases

Trajectory and determinants of agreement between parental and physicians' reports of childhood atopic dermatitis

Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany

Influence of FLG loss-of-function mutations in host–microbe interactions during atopic skin inflammation

Utilisation of supplementary prenatal screening and diagnostics in Germany: cross-sectional study using data from the KUNO Kids Health Study

Prevalences of cardiometabolic risk and lifestyle factors in young parents: evidence from a German birth cohort study

Atopic dermatitis in the pediatric population

Skin care interventions in infants for preventing eczema and food allergy

Skincare interventions in infants for preventing eczema and food allergy: A cochrane systematic review and individual participant data meta‐analysis